drugset / Trial / NCT07381803
The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction
Phase 3
Recruiting
2804 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Timeline
- Start
- 2025-01-27
- Primary completion
- 2026-12
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | 60 mg | Oral |
Indications
No indication recorded.